MART 1 peptide

MART 1 peptide is a synthetic peptide derived from the melanoma antigen recognized by T cells 1 (MART-1), a protein highly expressed in melanocytic cells and melanoma tumors. As a well-characterized epitope recognized by cytotoxic T lymphocytes (CTLs), MART 1 peptide plays a pivotal role in immunological research, particularly in studies focused on tumor immunology and antigen-specific immune responses. Its sequence is frequently utilized in the context of antigen presentation assays, T cell activation studies, and the evaluation of immune recognition mechanisms. The biochemical stability and defined immunogenicity of this peptide make it a valuable reagent for dissecting the molecular interactions between tumor antigens and the adaptive immune system.

Antigen presentation research: MART 1-derived sequences are widely employed to investigate the mechanisms of antigen processing and presentation by major histocompatibility complex (MHC) molecules. By loading antigen-presenting cells (APCs) with this peptide, researchers can study the efficiency and specificity of peptide-MHC complex formation, providing insights into the molecular determinants of immune recognition. Such studies are essential for elucidating the pathways involved in immune surveillance and the development of tumor-specific immune responses.

T cell activation assays: In immunological studies, the peptide is an indispensable tool for evaluating the activation, proliferation, and functional characteristics of MART-1-specific cytotoxic T lymphocytes. By exposing T cells to APCs pulsed with the peptide, researchers can monitor cytokine secretion, cytolytic activity, and T cell receptor (TCR) specificity. These functional assays are crucial for understanding T cell-mediated cytotoxicity and for optimizing protocols in adoptive cell transfer research.

Epitope mapping and immune monitoring: The defined sequence of MART 1 peptide enables precise mapping of T cell epitopes and facilitates the monitoring of antigen-specific immune responses in vitro. Researchers utilize this peptide to identify and characterize the repertoire of TCRs reactive to melanoma-associated antigens, supporting the development of diagnostic assays and the assessment of immune competence in experimental models. Such applications are instrumental in the preclinical evaluation of immunotherapeutic strategies.

Peptide-based vaccine development: As a prototypical tumor-associated antigen epitope, MART 1 peptide serves as a model system in the design and optimization of peptide-based vaccines for cancer immunotherapy research. Its capacity to elicit robust and specific T cell responses in vitro underpins studies aimed at enhancing antigen delivery, adjuvant selection, and immune potentiation. These investigations contribute to the rational design of next-generation immunotherapeutic approaches targeting melanoma and related malignancies.

Quality control and assay calibration: The well-defined sequence and immunological relevance of MART 1 peptide make it a preferred standard for calibrating immunoassays, including enzyme-linked immunospot (ELISpot) and flow cytometry-based detection of antigen-specific T cells. Consistent use of the peptide as a positive control ensures assay reproducibility and facilitates comparative studies across different experimental platforms. This application is fundamental for validating the sensitivity and specificity of immune monitoring assays in basic and translational research settings.

1. The spatiotemporal control of signalling and trafficking of the GLP-1R

2. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

3. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

4. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes